ARCHIVES

FDA Approves Velcade For Treatment Of Refractory Multiple Myeloma

This article is from The Cancer Letter archive.

Vol. 26 No. 5 | May 30, 2003

Download PDF Visit The Full Archive

Related Articles

FDA Approves Bexxar For Treatment Of Non-Hodgkin’s Lymphoma.

July 4, 2003

Professional Societies: Organizations Form Alliance To Call For Quality Cancer Care

October 9, 1998

NIH Guidelines Define Eligible Research Using Stem Cells.

September 8, 2000

Free Standing Cancer Center Firms Expanding Markets

February 21, 1986

In Brief: Ingell Vows To Broaden Indirect Cost Inquiry; Gallo, Fauci Make ‘Most Prolific Scientist’ List

February 7, 1992

Commission Seeks Comparative Data on Cervical Cancer

August 16, 1991